Corona Remedies Limited (CORONA)
Market Closed
10 Aug, 22:00
MSE MSE Primary XNSE ₹
2,082. 35
+21.4
+1.0384%
₹
103.87B Market Cap
- P/E Ratio
- Div Yield
2,249 Volume
- Eps
₹ 2,060.95
Previous Close Want to track CORONA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Corona Remedies Limited (CORONA) Statistics
Valuation metrics
Market Cap 103.87B
Enterprise value 105.1B
Trailing P/E (ttm) 56.03
Forward P/E 31.96
PEG ratio 68.14
Price/Sales (ttm) 7.4
Price/Book (mrq) 13.91
Enterprise Value/Revenue 7.49
Enterprise Value/EBITDA 35.81
Overview
Shares outstanding 61.16M
Float 6.18M
Shares short -
% Held by insiders 0.89%
% Held by institutions 0.07%
Average volume (10 days) 8.12K
Average volume (90 days) 8.49K
Price summary
52-Week low 1,062
52-Week high 2,261.4
Beta -
50-Day moving average 1,648.81
200-Day moving average 1,559.78
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.13%
Operating margin 0.15%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.27%
Income Statement
Revenue (ttm) 14.03B
Revenue per share (ttm) 229.44
Quarterly revenue growth (yoy) 0.2%
Gross profit (ttm) 11.42B
EBITDA 2.79B
Net income to common (ttm) 1.85B
Diluted EPS (ttm) 30.31
Quarterly earnings growth (yoy) 0.44%
Balance Sheet
Total cash (mrq) 441.2M
Total cash per share (mrq) 7.21
Total debt (mrq) 1.65B
Total Debt/Equity (mrq) 22.07
Current ratio (mrq) 0.96%
Book value per share (mrq) 122.09
Cash Flow
Cash flow statement 2.29B
Levered free cash flow (LFCF) 745.68M
